Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""CLOSTRIDIOIDES difficile"" wg kryterium: Temat


Tytuł:
Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study.
Autorzy:
Ghosh S; College of Medicine and Health, University College Cork, Cork, Ireland; University of Birmingham, Birmingham, UK.
Antunes A; IQVIA, Global Database Studies, Real World Solutions, Lisbon, Portugal. Electronic address: .
Rinta-Kokko H; IQVIA, Global Database Studies, Real World Solutions, Espoo, Finland.
Chaparova E; IQVIA, Real World Solutions, Sofia, Bulgaria.
Lay-Flurrie S; IQVIA, Real World Solutions, London, UK.
Tricotel A; IQVIA, Real World Solutions, Paris, France.
Andersson FL; Ferring Pharmaceuticals, Copenhagen, Denmark.
Pokaż więcej
Źródło:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Mar; Vol. 140, pp. 31-38. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Clostridium Infections*/drug therapy
Clostridium Infections*/epidemiology
Adult ; Humans ; Female ; Male ; Retrospective Studies ; Anti-Bacterial Agents/therapeutic use ; Risk Factors ; Recurrence
Czasopismo naukowe
Tytuł:
Pro-Inflammatory Cytokines Enhanced In Vitro Cytotoxic Activity of Clostridioides difficile Toxin B in Enteric Glial Cells: The Achilles Heel of Clostridioides difficile Infection?
Autorzy:
Fettucciari K; Biosciences & Medical Embryology Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Spaterna A; School of Biosciences and Veterinary Medicine, University of Camerino, 62024 Macerata, Italy.
Marconi P; Biosciences & Medical Embryology Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Bassotti G; Gastroenterology, Hepatology & Digestive Endoscopy Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Gastroenterology & Hepatology Unit, Santa Maria Della Misericordia Hospital, 06129 Perugia, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 12; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Bacterial Toxins*/toxicity
Antineoplastic Agents*
Clostridium Infections*
Boron Compounds*
Humans ; Cytokines ; Necrosis
Czasopismo naukowe
Tytuł:
Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance.
Autorzy:
Galley NF; School of Biosciences, University of Sheffield, Sheffield, UK.
Greetham D; School of Biosciences, University of Sheffield, Sheffield, UK.
Alamán-Zárate MG; School of Biosciences, University of Sheffield, Sheffield, UK.
Williamson MP; School of Biosciences, University of Sheffield, Sheffield, UK.
Evans CA; Department of Chemical and Biological Engineering, University of Sheffield, Sheffield, UK.
Spittal WD; Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research University of Leeds, Leeds, UK.
Buddle JE; School of Biosciences, University of Sheffield, Sheffield, UK.
Freeman J; Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research University of Leeds, Leeds, UK.
Davis GL; Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research University of Leeds, Leeds, UK.
Dickman MJ; Department of Chemical and Biological Engineering, University of Sheffield, Sheffield, UK.
Wilcox MH; Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Healthcare Associated Infections Research Group, Leeds Institute of Medical Research University of Leeds, Leeds, UK.
Lovering AL; School of Biosciences, University of Birmingham, Birmingham, UK.
Fagan RP; School of Biosciences, University of Sheffield, Sheffield, UK.
Mesnage S; School of Biosciences, University of Sheffield, Sheffield, UK. Electronic address: .
Pokaż więcej
Źródło:
The Journal of biological chemistry [J Biol Chem] 2024 Jan; Vol. 300 (1), pp. 105529. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Proteins*/chemistry
Clostridioides difficile*/enzymology
Clostridioides difficile*/genetics
Peptidoglycan*/chemistry
Peptidyl Transferases*/chemistry
Peptidyl Transferases*/genetics
beta-Lactam Resistance ; beta-Lactams/pharmacology ; Catalysis
Czasopismo naukowe
Tytuł:
Investigating the impact of antibiotic-induced dysbiosis on protection from Clostridium difficile colitis by mouse colonic innate lymphoid cells.
Autorzy:
Uddin MJ; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Thompson B; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Leslie JL; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.; Arcus Biosciences, Hayward, California, USA.
Fishman C; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Sol-Church K; Genome Analysis and Technology Core, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Kumar P; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Petri WA Jr; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Mar 13; Vol. 15 (3), pp. e0333823. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Enterocolitis, Pseudomembranous*
Clostridium Infections*/metabolism
Colitis*
Mice ; Animals ; Immunity, Innate ; Lymphocytes ; Anti-Bacterial Agents/pharmacology ; Interleukin-33/metabolism ; Interleukin-33/pharmacology ; Amphiregulin/metabolism ; Amphiregulin/pharmacology ; Dysbiosis
Czasopismo naukowe
Tytuł:
A rationally designed antimicrobial peptide from structural and functional insights of Clostridioides difficile translation initiation factor 1.
Autorzy:
Alanis E; School of Integrative Biological and Chemical Sciences, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Aguilar F; School of Integrative Biological and Chemical Sciences, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Banaei N; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.
Dean FB; School of Integrative Biological and Chemical Sciences, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Villarreal A; Department of Mechanical Engineering, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Alanis M; School of Integrative Biological and Chemical Sciences, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Lozano K; Department of Mechanical Engineering, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Bullard JM; School of Integrative Biological and Chemical Sciences, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Zhang Y; School of Integrative Biological and Chemical Sciences, The University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Pokaż więcej
Źródło:
Microbiology spectrum [Microbiol Spectr] 2024 Mar 05; Vol. 12 (3), pp. e0277323. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Bacterial Infections*
Humans ; Antimicrobial Peptides ; Cadmium ; Pandemics ; Peptide Initiation Factors ; Anti-Bacterial Agents/pharmacology
Czasopismo naukowe
Tytuł:
Characterizing the flavodoxin landscape in Clostridioides difficile .
Autorzy:
Troitzsch D; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Knop R; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Dittmann S; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Bartel J; Department of Microbial Proteomics, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Zühlke D; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Möller TA; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Trän L; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Echelmeyer T; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Sievers S; Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, University of Greifswald, Greifswald, Germany.
Pokaż więcej
Źródło:
Microbiology spectrum [Microbiol Spectr] 2024 Mar 05; Vol. 12 (3), pp. e0189523. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Flavodoxin*/metabolism
Clostridioides difficile*/genetics
Humans ; Clostridioides ; Ferredoxins ; Hydrogen Peroxide/metabolism ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Iron/metabolism
Czasopismo naukowe
Tytuł:
Outcomes of Clostridioides difficile infection in acute heart failure hospitalizations: insights from the National Inpatient Database.
Autorzy:
Duhan S; Department of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD, USA.
Taha A; Department of Internal Medicine, Louis A. Weiss Memorial Hospital, Chicago, IL, USA.
Keisham B; Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore, MD, USA.
Badu I; Department of Internal Medicine, Onslow Memorial Hospital, Jacksonville, NC, USA.
Atti L; Department of Internal Medicine, Michigan State University, MI, USA.
Hussein MH; Department of Internal Medicine, Saint Joseph Hospital, Chicago, IL, USA.
Sandhyavenu H; Department of Internal Medicine, Louis A. Weiss Memorial Hospital, Chicago, IL, USA.
Uppal D; Department of Cardiology, Cleveland Clinic, Weston, FL, USA.
Tantry US; Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore, MD, USA.
Bliden KP; Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore, MD, USA.
Tarff A; Department of Internal Medicine, Louis A. Weiss Memorial Hospital, Chicago, IL, USA.
Ali S; Department of Internal Medicine, Louisiana State University, Shreveport, LA, USA.
Ali S; Department of Internal Medicine, Louis A. Weiss Memorial Hospital, Chicago, IL, USA.
Rout A; Division of Cardiology, University of Louisville, Louisville, KY, USA. Electronic address: .
Gurbel PA; Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore, MD, USA.
Pokaż więcej
Źródło:
The Journal of hospital infection [J Hosp Infect] 2024 Mar; Vol. 145, pp. 129-139. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Clostridium Infections*/diagnosis
Heart Failure*/complications
Heart Failure*/epidemiology
Humans ; Inpatients ; Hospitalization ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD 7 .
Autorzy:
Kinsolving J; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, 17165 Stockholm, Sweden.
Bous J; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, 17165 Stockholm, Sweden.
Kozielewicz P; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, 17165 Stockholm, Sweden.
Košenina S; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Shekhani R; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, 17165 Stockholm, Sweden.
Grätz L; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, 17165 Stockholm, Sweden.
Masuyer G; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Wang Y; Department of Urology, Boston Children's Hospital, Department of Surgery and Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Stenmark P; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Dong M; Department of Urology, Boston Children's Hospital, Department of Surgery and Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Schulte G; Karolinska Institutet, Department Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum, 17165 Stockholm, Sweden. Electronic address: .
Pokaż więcej
Źródło:
Cell reports [Cell Rep] 2024 Feb 27; Vol. 43 (2), pp. 113727. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Toxins*
Clostridioides difficile*
Clostridium Infections*
Boron Compounds*
Humans ; Cryoelectron Microscopy
Czasopismo naukowe
Tytuł:
The microbial metabolite urolithin A reduces Clostridioides difficile toxin expression and toxin-induced epithelial damage.
Autorzy:
Ghosh S; Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.; UofL-Brown Cancer Center, Louisville, Kentucky, USA.
Erickson D; Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.
Chua MJ; Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.
Collins J; Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.; Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA.; Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, Kentucky, USA.
Jala VR; Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.; UofL-Brown Cancer Center, Louisville, Kentucky, USA.; Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, Kentucky, USA.; Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky, USA.
Pokaż więcej
Źródło:
MSystems [mSystems] 2024 Feb 20; Vol. 9 (2), pp. e0125523. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Toxins*/genetics
Clostridioides difficile*/metabolism
Enterocolitis, Pseudomembranous*/drug therapy
Clostridium Infections*/drug therapy
Colitis*/chemically induced
Coumarins*
Animals ; Mice ; Enterotoxins/genetics ; Bacterial Proteins/genetics
Czasopismo naukowe
Tytuł:
Clostridioides difficile Flagella.
Autorzy:
Marvaud JC; Institut MICALIS, INRAE, AgroParisTech, Equipe Bactéries Pathogènes et Santé, Faculté de Pharmacie, Université Paris-Saclay, 91400 Orsay, France.
Bouttier S; Institut MICALIS, INRAE, AgroParisTech, Equipe Bactéries Pathogènes et Santé, Faculté de Pharmacie, Université Paris-Saclay, 91400 Orsay, France.
Saunier J; Matériaux et Santé, Faculté de pharmacie, Université Paris Saclay, 91400 Orsay, France.
Kansau I; Institut MICALIS, INRAE, AgroParisTech, Equipe Bactéries Pathogènes et Santé, Faculté de Pharmacie, Université Paris-Saclay, 91400 Orsay, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 12; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clostridioides difficile*/genetics
Gastrointestinal Microbiome*
Humans ; Flagella/genetics
Czasopismo naukowe
Tytuł:
Multimodal vaccination targeting the receptor binding domains of Clostridioides difficile toxins A and B with an attenuated Salmonella Typhimurium vector (YS1646) protects mice from lethal challenge.
Autorzy:
Winter K; Department of Microbiology and Immunology, McGill University, Montreal, Québec, Canada.; Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
Houle S; Institut National de Recherche Scientifique-Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada.
Dozois CM; Institut National de Recherche Scientifique-Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada.
Ward BJ; Department of Microbiology and Immunology, McGill University, Montreal, Québec, Canada.; Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
Pokaż więcej
Źródło:
Microbiology spectrum [Microbiol Spectr] 2024 Feb 06; Vol. 12 (2), pp. e0310922. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Toxins*/genetics
Clostridioides difficile*/genetics
Boron Compounds*
Humans ; Animals ; Mice ; Aged ; Salmonella typhimurium/genetics ; Bacterial Vaccines ; Vaccines, Synthetic ; Vaccination ; Immunoglobulin G ; Immunoglobulin A
Czasopismo naukowe
Tytuł:
Rethinking Clostridioides difficile infection (CDI) surveillance definitions based on changing healthcare utilisation and a more realistic incubation period: reviewing data from a tertiary-referral hospital, Ireland, 2012 to 2021.
Autorzy:
Skally M; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.; Department of Clinical Microbiology, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile - ESGCD, Basel Switzerland.; These authors contributed equally to this work and share first/last authorship.
Bennett K; Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Humphreys H; Department of Clinical Microbiology, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Fitzpatrick F; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.; Department of Clinical Microbiology, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile - ESGCD, Basel Switzerland.; These authors contributed equally to this work and share first/last authorship.
Pokaż więcej
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (6).
Typ publikacji:
Journal Article
MeSH Terms:
Community-Acquired Infections*/epidemiology
Clostridioides difficile*
Clostridium Infections*/diagnosis
Clostridium Infections*/epidemiology
Cross Infection*/epidemiology
Cross Infection*/diagnosis
Humans ; Ireland/epidemiology ; Tertiary Care Centers ; Delivery of Health Care ; Patient Acceptance of Health Care ; Referral and Consultation
Czasopismo naukowe
Tytuł:
Equine fecal microbiota response to short term antibiotic administration.
Autorzy:
Parker JL; Department of Veterinary Science, Gluck Equine Research Center, College of Agriculture, Food, and Environment, University of Kentucky, 1400 Nicholasville Rd., Lexington, KY 40546, USA.
Page A; Department of Veterinary Science, Gluck Equine Research Center, College of Agriculture, Food, and Environment, University of Kentucky, 1400 Nicholasville Rd., Lexington, KY 40546, USA.
Jacob O; Department of Veterinary Science, Gluck Equine Research Center, College of Agriculture, Food, and Environment, University of Kentucky, 1400 Nicholasville Rd., Lexington, KY 40546, USA.
Stanton V; Department of Statistics, College of Arts and Sciences, University of Kentucky, 725 Rose St., Lexington, KY 40536, USA.
Davis B; Forage-Animal Production Research Unit, Agricultural Research Service, United States Department of Agriculture, 1100 Nicholasville Rd., Lexington, KY 40546, USA; Department of Animal & Food Sciences, College of Agriculture, Food, and Environment, University of Kentucky, 325 Cooper Dr., Lexington, KY 40546, USA.
Flythe M; Forage-Animal Production Research Unit, Agricultural Research Service, United States Department of Agriculture, 1100 Nicholasville Rd., Lexington, KY 40546, USA; Department of Animal & Food Sciences, College of Agriculture, Food, and Environment, University of Kentucky, 325 Cooper Dr., Lexington, KY 40546, USA.
Adam EN; Department of Veterinary Science, Gluck Equine Research Center, College of Agriculture, Food, and Environment, University of Kentucky, 1400 Nicholasville Rd., Lexington, KY 40546, USA. Electronic address: .
Pokaż więcej
Źródło:
Journal of equine veterinary science [J Equine Vet Sci] 2024 Feb; Vol. 133, pp. 104993. Date of Electronic Publication: 2024 Jan 01.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Microbiota*
Animals ; Horses ; Anti-Bacterial Agents/adverse effects ; Feces/microbiology ; Bacteria
Czasopismo naukowe
Tytuł:
Liberation of host heme by Clostridioides difficile- mediated damage enhances Enterococcus faecalis fitness during infection.
Autorzy:
Smith AB; Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Specker JT; Department of Chemistry, University of Florida, Gainesville, Florida, USA.
Hewlett KK; Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Scoggins TR 4th; Department of Chemistry, University of Florida, Gainesville, Florida, USA.
Knight M; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Lustig AM; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Li Y; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Tsinghua University School of Medicine, Beijing, China.
Evans KM; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Guo Y; Department of Chemistry, University of Florida, Gainesville, Florida, USA.
She Q; Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Christopher MW; Department of Chemistry, University of Florida, Gainesville, Florida, USA.
Garrett TJ; Department of Chemistry, University of Florida, Gainesville, Florida, USA.; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Moustafa AM; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Van Tyne D; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Prentice BM; Department of Chemistry, University of Florida, Gainesville, Florida, USA.
Zackular JP; Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Jan 16; Vol. 15 (1), pp. e0165623. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Clostridium Infections*/microbiology
Gastrointestinal Microbiome*
Humans ; Enterococcus faecalis ; Bacteria
Czasopismo naukowe
Tytuł:
The anti-inflammatory and anti-apoptotic effects of Achillea millefolium L. extracts on Clostridioides difficile ribotype 001 in human intestinal epithelial cells.
Autorzy:
Raeisi H; Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Azimirad M; Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Asadi-Sanam S; Medicinal Plants Research Division, Research Institute of Forests and Rangelands, Agricultural Research, Education & Extension Organization (AREEO), Tehran, Iran.
Asadzadeh Aghdaei H; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Yadegar A; Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Zali MR; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
BMC complementary medicine and therapies [BMC Complement Med Ther] 2024 Jan 13; Vol. 24 (1), pp. 37. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*/genetics
Achillea*/chemistry
Achillea*/genetics
Anti-Infective Agents*
Animals ; Chlorocebus aethiops ; Humans ; Caco-2 Cells ; Ribotyping ; Vero Cells ; Epithelial Cells ; Anti-Inflammatory Agents/pharmacology ; Phytochemicals
Czasopismo naukowe
Tytuł:
A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from Clostridioides difficile .
Autorzy:
Sapa D; Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, 78350 Jouy-en-Josas, France.
Brosse A; Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, 78350 Jouy-en-Josas, France.
Coullon H; Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, 78350 Jouy-en-Josas, France.
Péan de Ponfilly G; Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, 78350 Jouy-en-Josas, France.; Service de Microbiologie Clinique, GH Paris Saint-Joseph, 75674 Paris, France.
Candela T; Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, 78350 Jouy-en-Josas, France.
Le Monnier A; Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, 78350 Jouy-en-Josas, France.; Service de Microbiologie Clinique, GH Paris Saint-Joseph, 75674 Paris, France.
Pokaż więcej
Źródło:
Toxins [Toxins (Basel)] 2024 Jan 11; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*/genetics
Bacterial Toxins*/genetics
Bacterial Toxins*/toxicity
Enterotoxins/genetics ; Enterotoxins/toxicity ; Virulence Factors ; Anti-Bacterial Agents
Czasopismo naukowe
Tytuł:
Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology.
Autorzy:
Hunault L; Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France.; Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, France.; Collège doctoral, Sorbonne Université, Paris, France.
Auria E; Laboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Université Paris-Cité, UMR-CNRS 6047, Paris, France.
England P; Department of Structural Biology and Chemistry, Institut Pasteur, Université Paris Cité, CNRS UMR3528, Plateforme de Biophysique Moléculaire, Paris, France.
Deschamps J; Institut Micalis, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, France.
Briandet R; Institut Micalis, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, France.
Kremer V; Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, France.; Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, Inserm, Châtenay-Malabry, France.
Iannascoli B; Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, France.
Vidal-Maison L; Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France.
Guo C; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
Macdonald L; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
Péchiné S; Equipe Bactéries Pathogènes et Santé, Faculté de Pharmacie, Institut MICALIS (UMR 1319 Université Paris-Saclay, INRAE, AgroParisTech), Orsay, France.
Denève-Larrazet C; Equipe Bactéries Pathogènes et Santé, Faculté de Pharmacie, Institut MICALIS (UMR 1319 Université Paris-Saclay, INRAE, AgroParisTech), Orsay, France.
Dupuy B; Laboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Université Paris-Cité, UMR-CNRS 6047, Paris, France.
Gorochov G; Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France.
Bruhns P; Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, France.
Sterlin D; Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France.
Pokaż więcej
Źródło:
Gut microbes [Gut Microbes] 2024 Jan-Dec; Vol. 16 (1), pp. 2301147. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Gastrointestinal Microbiome*
Adult ; Humans ; Antibodies, Monoclonal/therapeutic use ; Cell Death
Czasopismo naukowe
Tytuł:
Hyperbaric oxygen augments susceptibility to C. difficile infection by impairing gut microbiota ability to stimulate the HIF-1α-IL-22 axis in ILC3.
Autorzy:
Fachi JL; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Pral LP; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.
Assis HC; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.
Oliveira S; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.
Rodovalho VR; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.
Dos Santos JAC; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.
Fernandes MF; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.
Matheus VA; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.
Sesti-Costa R; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil.
Basso PJ; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Flóro E Silva M; Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, Brazil.
Câmara NOS; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Giorgio S; Department of Animal Biology, Institute of Biology, University of Campinas, Campinas, Brazil.
Colonna M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Vinolo MAR; Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.; Experimental Medicine Research Cluster, Institute of Biology, University of Campinas, Campinas, Brazil.; Obesity and Comorbidities Research Center (OCRC), University of Campinas, Campinas, Brazil.
Pokaż więcej
Źródło:
Gut microbes [Gut Microbes] 2024 Jan-Dec; Vol. 16 (1), pp. 2297872. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Microbiome*
Clostridioides difficile*
Hyperbaric Oxygenation*/adverse effects
Clostridium Infections*
Mice ; Animals ; Nuclear Receptor Subfamily 1, Group F, Member 3 ; Immunity, Innate ; Interleukin-22 ; Dysbiosis/therapy ; Lymphocytes ; Butyrates/pharmacology ; Fatty Acids, Volatile/pharmacology ; Anti-Bacterial Agents/pharmacology
Czasopismo naukowe
Tytuł:
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
Autorzy:
Spartz EJ; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
DeDecker LC; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
Fansiwala KM; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
Noorian S; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
Roney AR; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
Hakimian S; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
Sauk JS; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
Chen PH; Division of Gastroenterology & Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Limketkai BN; Center for Inflammatory Bowel Diseases, UCLA School of Medicine, Los Angeles, California, USA.; Vatche & Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jan; Vol. 59 (1), pp. 89-99. Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/epidemiology
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/epidemiology
Crohn Disease*/complications
Crohn Disease*/diagnosis
Crohn Disease*/epidemiology
Clostridium Infections*/diagnosis
Clostridium Infections*/epidemiology
Humans ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting.
Autorzy:
Newcomer EP; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.
Fishbein SRS; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA.; Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Zhang K; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA.; Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Hink T; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Reske KA; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Cass C; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Iqbal ZH; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Struttmann EL; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Burnham C-AD; Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Dubberke ER; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Dantas G; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.; Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Mar 13; Vol. 15 (3), pp. e0330023. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*/genetics
Clostridium Infections*/epidemiology
Humans ; Virulence ; Genomics ; Diarrhea
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies